423 related articles for article (PubMed ID: 14973392)
1. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells.
Safe S; Wormke M; Samudio I
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):295-306. PubMed ID: 14973392
[TBL] [Abstract][Full Text] [Related]
2. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between estrogen receptor alpha and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes.
Wormke M; Stoner M; Saville B; Safe S
FEBS Lett; 2000 Jul; 478(1-2):109-12. PubMed ID: 10922479
[TBL] [Abstract][Full Text] [Related]
4. The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.
Wormke M; Stoner M; Saville B; Walker K; Abdelrahim M; Burghardt R; Safe S
Mol Cell Biol; 2003 Mar; 23(6):1843-55. PubMed ID: 12612060
[TBL] [Abstract][Full Text] [Related]
5. The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.
Klinge CM; Kaur K; Swanson HI
Arch Biochem Biophys; 2000 Jan; 373(1):163-74. PubMed ID: 10620335
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
[TBL] [Abstract][Full Text] [Related]
7. The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.
Hockings JK; Thorne PA; Kemp MQ; Morgan SS; Selmin O; Romagnolo DF
Cancer Res; 2006 Feb; 66(4):2224-32. PubMed ID: 16489025
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
Wormke M; Castro-Rivera E; Chen I; Safe S
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (Review).
Safe S; McDougal A
Int J Oncol; 2002 Jun; 20(6):1123-8. PubMed ID: 12011988
[TBL] [Abstract][Full Text] [Related]
10. Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes.
Wang F; Hoivik D; Pollenz R; Safe S
Nucleic Acids Res; 1998 Jun; 26(12):3044-52. PubMed ID: 9611253
[TBL] [Abstract][Full Text] [Related]
11. ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription.
Beischlag TV; Perdew GH
J Biol Chem; 2005 Jun; 280(22):21607-11. PubMed ID: 15837795
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of cathepsin D gene expression by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.
Wang F; Samudio I; Safe S
Mol Cell Endocrinol; 2001 Feb; 172(1-2):91-103. PubMed ID: 11165043
[TBL] [Abstract][Full Text] [Related]
13. Zinc finger nuclease-mediated knockout of AHR or ARNT in human breast cancer cells abolishes basal and ligand-dependent regulation of CYP1B1 and differentially affects estrogen receptor α transactivation.
Ahmed S; Wang A; Celius T; Matthews J
Toxicol Sci; 2014 Mar; 138(1):89-103. PubMed ID: 24299737
[TBL] [Abstract][Full Text] [Related]
14. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms.
Safe S; Wang F; Porter W; Duan R; McDougal A
Toxicol Lett; 1998 Dec; 102-103():343-7. PubMed ID: 10022276
[TBL] [Abstract][Full Text] [Related]
15. Dioxin and estrogen signaling in lung adenocarcinoma cells with different aryl hydrocarbon receptor/estrogen receptor α phenotypes.
Kuo LC; Cheng LC; Lin CJ; Li LA
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1064-73. PubMed ID: 23855798
[TBL] [Abstract][Full Text] [Related]
16. Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models.
Go RE; Hwang KA; Kim CW; Byun YS; Nam KH; Choi KC
Environ Toxicol; 2017 Oct; 32(10):2225-2233. PubMed ID: 28618207
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S
Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542
[TBL] [Abstract][Full Text] [Related]
18. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines.
Labrecque MP; Takhar MK; Hollingshead BD; Prefontaine GG; Perdew GH; Beischlag TV
PLoS One; 2012; 7(1):e29545. PubMed ID: 22235307
[TBL] [Abstract][Full Text] [Related]
20. Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer.
Safe S; Qin C; McDougal A
Expert Opin Investig Drugs; 1999 Sep; 8(9):1385-96. PubMed ID: 15992156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
